Abstract

The safety and efficacy of multivitamin-multimineral-multiherbal (MVMH) supplementation is in regular debate but should be studied in detail before recommendation. The purpose of the study was to evaluate whether MVMH supplementation affects the physical and mental performance of individuals taking these, as well as to ascertain its safety, doing so through blood, kidney and liver profiles.

In this Cross over cohort study, we enrolled 30 healthy volunteers and established their anthropometric, stress, anxiety and depression levels before and after 30 days of the study. Their kidney function test, liver function test and blood profile results were also analysed to determine overall health effects of the supplement and assess its safety. Parametric data was examined via Paired T test, followed by One Way ANOVA, Non-parametric data is presented as percentage and analysed by applying Paired Sample Wilcoxon Signal Rank Test followed by Friedman ANOVA test.

All the volunteers were in good health, had no change in medical state. No serious adverse event was reported during the study and after the completion of study. Treatment with MVMH tablets had shown very significant (p <0.01) increase in the level of globulin, uric acid (p <0.05), hemoglobin, and hematocrit levels (p <0.05), BMI and body weight (p <0.05). There was significant (p <0.05) improvement in symptoms of anxiety, depression and stress.

The daily intake of MVMH supplements in the form of a tablet once per day improved global health of individuals, along with improvement in mental performance without any significant adverse impact on the body. Based on the results, we recommend that MVMH tablets may be taken once per day for 30 days to improve the physical and mental health of individuals.

Details

Title
Impact of dietary and herbal supplements on global health of adult volunteers
Author
Tomer, Abhilasha 1   VIAFID ORCID Logo  ; Sarkar, Amlan Kanti 2   VIAFID ORCID Logo  ; Chitme, Havagiray R 3   VIAFID ORCID Logo 

 Faculty of Pharmacy, DIT University Dehradun, India 
 Institute of Clinical Research India, New Delhi, India 
 Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, India 
Pages
38-46
Publication year
2024
Publication date
2024
Publisher
De Gruyter Poland
ISSN
2084980X
e-ISSN
23006676
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3159412497
Copyright
© 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.